Cardiac injury and shock can occur in pediatric patients with COVID-19.
Lopinavir/ritonavir (LPV/RTV) treatment of COVID-19 is associated with an increased risk for bradycardia.
Cardiac troponin may aid clinicians in determining stage classification and stratifying risk for myocardial injury among patients with COVID-19.
A long short-term memory model was able to decipher 12 common heart rhythms using data from 12-lead electrocardiograms.
Cardiac arrests and arrhythmias observed in patients with COVID-19 were found to result from infection by the virus as well as systemic conditions.
Treatment with the thrombin inhibitor dabigatran was associated with a decreased incidence of Staphylococcus aureus bacteremia compared with treatment with the factor Xa inhibitors rivaroxaban and apixaban.
The American Heart Association outlined several considerations for the management of pregnant women with CVD or CVD-related conditions.
Nonpersistent pre-excitation was associated with fewer high-risk accessory pathway in children with Wolff-Parkinson-White syndrome.
Regular coffee consumption is associated with a significantly lower risk for arrhythmias.
Among patients with permanent atrial fibrillation, cognitive impairment may be more common in those with suboptimal antithrombotic therapy, oral anticoagulation, or heart rate control.